5月19日至5月23日,世界骨肿瘤大师Donati教授再次到访深圳市第二人民医院担任国际客座教授。Donati教授所就职的意大利里佐利骨科研究所,在2025年,被美国新闻周刊评选为世界十大著名骨科机构,其在骨与软组织肿瘤治疗方面已有一百多年的历史,是欧洲乃至世界最著名的骨肿瘤中心。在一周的交流里,Donati教授在骨关节骨肿瘤外科孙炜主任及其带领下的骨肿瘤团队李伟主任、郑传禧医师、徐刚医师陪同下,通过门诊查房、手术指导、疑难病例讨论、科室管理培训、大师公开课等形式继续深入分享里佐利骨科研究所骨与软组织肿瘤的诊疗理念以及临床经验。此次与骨肿瘤团队的学术交流不仅是对于某个细节问题或者单纯的手术技术的讨论,更多聚焦在骨肿瘤中心的搭建、骨肿瘤专科人才的培养以及多学科团队协作等问题的探讨。Donati教授强调这三方面是衡量一个地区可提供专业化骨肿瘤诊疗的关键因素,是需要当地政府、医院领导层以及外科医生和相关医护人员共同努力去提升的。骨肿瘤手术与骨科手术完全不同,其诊疗的理念也完全不同,骨肿瘤外科医生不仅要学会当一名外科医生还需要学会当一名骨肿瘤科学家,这就需要其学习肿瘤知识、积累丰富的骨肿瘤治疗经验并相应开展大量的科学研究,才能够成长为合格的骨肿瘤外科医生;而一个良好运作的骨肿瘤中心,除了需配备相关医疗设备外,需要有一个经验丰富的骨肿瘤多学科团队,包括骨肿瘤外科医生、病理学家、肿瘤内科专家、影像科专家、放射科专家等。参照欧洲的骨肿瘤中心数量以及骨肿瘤的发病率,一个地区里每1000万人口需要有一个骨肿瘤中心。深圳市目前约有1700万人口,建立两个骨肿瘤中心就可满足当地骨肿瘤病人的需求。因此,Donati教授建议当地骨肿瘤病人可汇集到一到两个骨肿瘤中心进行治疗,而不是分散到当地各家医院进行治疗。因为通过积累大量骨肿瘤的诊疗经验,这不仅有利于搭建一个专业化的骨肿瘤多学科团队,也便于进行科学研究。访问结束的最后一天,深圳市二骨肿瘤团队全员送别Donati教授,对其一周的指导与分享表示诚挚的感谢。明年3月深圳市二将会派出一名青年医生到访里佐利骨科研究所骨肿瘤科访问学习,学成归国后,希望能够引进更多国外先进的理念,为当地搭建专业化的骨肿瘤中心贡献一份力量。
From May 19th to May 23rd, Prof. Donati, the World-class Master on Bone Tumor, visited Shenzhen Second People's Hospital for the second time as an international visiting professor. he Rizzoli Orthopaedic Institute in Italy, where Prof. Donati works, is ranked as one of the top ten orthopaedic institutions in the world by Newsweek in 2025.It has a history of over 100 years in the treatment of bone and soft tissue tumors, and is recognized as the most famous bone tumor center in Europe and even around the world. During the one-week visit, Prof. Donati, accompanied by SUN Wei, Director of Department of Bone and Joint Surgery and Musculoskeletal Tumor Surgery and Director LI Wei, Dr. ZHENG Chuanxi and Dr. XU Gang from the bone tumor team, continued to share the diagnosis and treatment concepts and clinical experiences in bone and soft tissue tumors of Rizzoli Orthopaedic Institute through a series of activities, like outpatient clinics and ward round, surgical guidance, discussion of difficult cases, training on department management and public lecture, etc. he academic exchanges with the bone tumor team were not only about discussing a specific point or purely surgical techniques, but also focused on the establishment of bone tumor center, the training of bone tumor surgeon, and multidisciplinary collaboration, etc. Prof. Donati pointed out that these are the three key factors to evaluate the capability of providing professional treatment for bone tumor patients in a region. And the improvement of them needs to be addressed by the local government, the leaders of hospitals, as well as surgeons and related medical staffs in a joint effort. Bone tumor surgery is completely different from orthopedic surgery, and its diagnosis and treatment concepts are also a totally different thing. one tumor surgeons should not only learn to be a surgeon, but also should learn to be a scientist in bone oncology. his requires them to learn knowledge about oncology, accumulate extensive experience in treating bone tumors, and conduct a large amount of scientific research, in this way they could grow to be a qualified bone tumor surgeon; In addition to be equipped with medical equipment, a well-functioning bone tumor center requires an experienced multidisciplinary bone tumor team, including bone tumor surgeons, pathologists, medical oncologists, imaging specialists, radiologists, and so on. With reference to the number of bone tumor centers in Europe and the incidence rate of bone tumors, one bone tumor center is needed for a region with a population of 10 million people. Shenzhen, with a current population of approximately 17 million, would require the establishment of two bone tumor centers to adequately meet the clinical needs of local patients with bone tumors. Therefore, Prof. Donati suggested that the local bone tumor patients can be collected and sent to one or two bone tumor centers in Shenzhen for treatment, instead of being treated in different local hospitals. Because this approach allows for the accumulation of extensive clinical experience in bone tumor treatment, which not only facilitates the development of a specialized multidisciplinary team focused on bone tumors but also enhances scientific research capabilities. n the last day of the visit, the whole bone tumor team of Shenzhen Second People's Hospital sent Prof. Donati off and expressed their sincere thankfulness for his one-week guidance and sharing. In March 2026, Shenzhen Second People's Hospital will send a young doctor to visit the Department of Orthopaedic Oncology of Rizzoli Orthopaedic Institute for fellowship. fter returning home, we hope that he could bring more advanced concepts from abroad and contribute to the building of a specialized bone tumor center in the region.